447 related articles for article (PubMed ID: 9923893)
1. Role of maintenance treatment in opioid dependence.
Ward J; Hall W; Mattick RP
Lancet; 1999 Jan; 353(9148):221-6. PubMed ID: 9923893
[TBL] [Abstract][Full Text] [Related]
2. Problem based review: The patient taking methadone.
Arora A; Williams K
Acute Med; 2013; 12(1):51-4. PubMed ID: 23539377
[TBL] [Abstract][Full Text] [Related]
3. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
Ngo HT; Tait RJ; Hulse GK
Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
[TBL] [Abstract][Full Text] [Related]
4. Depression in methadone maintenance treatment patients: rate and risk factors.
Peles E; Schreiber S; Naumovsky Y; Adelson M
J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
[TBL] [Abstract][Full Text] [Related]
5. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.
Sees KL; Delucchi KL; Masson C; Rosen A; Clark HW; Robillard H; Banys P; Hall SM
JAMA; 2000 Mar; 283(10):1303-10. PubMed ID: 10714729
[TBL] [Abstract][Full Text] [Related]
6. The impact of benzodiazepine use on methadone maintenance treatment outcomes.
Brands B; Blake J; Marsh DC; Sproule B; Jeyapalan R; Li S
J Addict Dis; 2008; 27(3):37-48. PubMed ID: 18956528
[TBL] [Abstract][Full Text] [Related]
7. Maintenance therapy for opioid addiction with methadone, LAAM and buprenorphine: the Emperor's New Clothes Phenomenon.
Stimmel B
J Addict Dis; 2001; 20(4):1-5. PubMed ID: 11760922
[No Abstract] [Full Text] [Related]
8. Methadone as social control: institutionalized stigma and the prospect of recovery.
Harris J; McElrath K
Qual Health Res; 2012 Jun; 22(6):810-24. PubMed ID: 22232295
[TBL] [Abstract][Full Text] [Related]
9. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
White WL; Campbell MD; Spencer RD; Hoffman HA; Crissman B; DuPont RL
J Psychoactive Drugs; 2014; 46(2):114-22. PubMed ID: 25052787
[TBL] [Abstract][Full Text] [Related]
10. Innovations in agonist maintenance treatment of opioid-dependent patients.
Haasen C; van den Brink W
Curr Opin Psychiatry; 2006 Nov; 19(6):631-6. PubMed ID: 17012944
[TBL] [Abstract][Full Text] [Related]
11. [Buprenorphine or methadone for detoxification of young opioid addicts?].
Ebner R; Schreiber W; Zierer C
Psychiatr Prax; 2004 Nov; 31 Suppl 1():S108-10. PubMed ID: 15570521
[TBL] [Abstract][Full Text] [Related]
12. Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial.
Magura S; Lee JD; Hershberger J; Joseph H; Marsch L; Shropshire C; Rosenblum A
Drug Alcohol Depend; 2009 Jan; 99(1-3):222-30. PubMed ID: 18930603
[TBL] [Abstract][Full Text] [Related]
13. Symptom complaints of patients prescribed either oral methadone or injectable heroin.
Dürsteler-MacFarland KM; Fischer DA; Mueller S; Schmid O; Moldovanyi A; Wiesbeck GA
J Subst Abuse Treat; 2010 Jun; 38(4):328-37. PubMed ID: 20206457
[TBL] [Abstract][Full Text] [Related]
14. Buprenorphine for heroin addicts: the issue of illicit opioid abuse during maintenance.
Cho E; Dermatis H; Galanter M
Subst Abus; 2006 Jun; 27(1-2):1-3. PubMed ID: 17062539
[No Abstract] [Full Text] [Related]
15. [Influence of psychiatric disorders in the effectiveness of a long-term methadone maintenance treatment].
Fernández Miranda J; González García-Portilla M; Sáiz Martínez P; Gutiérrez Cienfuegos E; Bobes García J
Actas Esp Psiquiatr; 2001; 29(4):228-32. PubMed ID: 11470057
[TBL] [Abstract][Full Text] [Related]
16. Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).
Digiusto E; Shakeshaft A; Ritter A; O'Brien S; Mattick RP;
Addiction; 2004 Apr; 99(4):450-60. PubMed ID: 15049745
[TBL] [Abstract][Full Text] [Related]
17. Psychotherapeutic benefits of opioid agonist therapy.
Tenore PL
J Addict Dis; 2008; 27(3):49-65. PubMed ID: 18956529
[TBL] [Abstract][Full Text] [Related]
18. [Blessing or problem child? Substitution therapy for opiate-addicted patients].
Pallenbach E
Pharm Unserer Zeit; 2002; 31(1):90-5. PubMed ID: 11852662
[No Abstract] [Full Text] [Related]
19. Comparing overdose mortality associated with methadone and buprenorphine treatment.
Bell JR; Butler B; Lawrance A; Batey R; Salmelainen P
Drug Alcohol Depend; 2009 Sep; 104(1-2):73-7. PubMed ID: 19443138
[TBL] [Abstract][Full Text] [Related]
20. Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis.
Farré M; Mas A; Torrens M; Moreno V; Camí J
Drug Alcohol Depend; 2002 Feb; 65(3):283-90. PubMed ID: 11841899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
